• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Keep your balance — even in old age

Bioengineer by Bioengineer
May 29, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Neurogeriatrics Research Group, Kiel University

Balance problems when standing and walking are ubiquitous in the older population, and can lead to a significant burden for the individual and society. To date, pharmacological and non-pharmacological treatments have produced limited results highlighting an area of significant need for older adults. This need is the focus of the Innovative Training Network (ITN) "Keep Control", through funding provided by the European Commission of more than €3 million over the next four years, as a Marie Sk?odowska-Curie grant under the "Horizon 2020" research and innovation programme. Approximately half a million euros from this goes to Kiel University.

"Keep Control" is coordinated by Professor Walter Maetzler from the Faculty of Medicine at Kiel University, and deputy director of the Department of Neurology at the University Medical Center Schleswig-Holstein (UKSH). The consortium consists of a total of 12 European locations encompassing neurological, geriatric, biomechanic and statistical research, as well as experts from industry. The objectives are a better understanding of balance and gait deficits in older adults, as well as the search for innovative treatment options.

"Balance disorders and gait problems can lead to life-threatening situations, not only for people with neurodegenerative diseases," says Maetzler. "These problems also often occur in otherwise active and vivacious older people. They lose their independence and mobility, which then also impacts their well-being and quality of life."

The scientists involved are applying new technical methods, to enhance diagnosis in the early stages of gait and balance deficits. They are also carrying out therapy studies with fall-prone older people. A special feature of the project is the collection of data with software that enables both a joint evaluation of the data at all locations, as well as allowing study participants to interpret and contribute their own data . "In addition to research, the second focus of the project is clearly the promotion of early stage researchers, which we are spending a large portion of our funding on," explained Maetzler. As such, 12 positions for doctoral candidates are currently being advertised.

###

More information about the project: http://www.keep-control.eu

An image on this topic is available for download under: http://www.uni-kiel.de/download/pm/2017/2017-150-1.png
Caption: In the Innovative Training Network (ITN) "Keep Control" scientists research gait and balance deficits.
Copyright: Neurogeriatrics Research Group, Kiel University

Contact:
Prof. Dr Walter Maetzler
The Department of Neurology
Tel.: +49 (0)431 500 -23981
E-mail: [email protected]

Background information: "Horizon 2020" is the current framework programme of the European Union for the promotion of research and innovation. With its multidisciplinary, mission-orientated approach, it encompasses the entire innovation cycle, and thus promotes cooperation and the exchange of ideas. The goal: enabling scientific discoveries, and further improving cooperation between science and business. With funding of approximately €70 billion, "Horizon 2020" is the world's largest integrated research and innovation programme. "Horizon 2020" covers both fundamental research as well as application-orientated research fields.

Marie Sk?odowska-Curie actions are a line of funding within "Horizon 2020", to encourage transnational and intersectoral mobility and career development of internationally-mobile scientists, and to increase the attractiveness of scientific careers.

Project title: Keep Control (Industrial Academic Initial Training Network towards specific diagnosis and treatment of age-related gait and balance deficits)
Start of funding: 1 March 2017
Duration of funding: 48 months
Budget: € 3.06 million
Coordination: Kiel University

Overview of the Keep Control project partners
Belgium
University of Leuven

Germany
Kiel University
Ludwig-Maximilians-Universität München / LMU Munich
Hasomed Hard-und Software für Medizin GmbH, Magdeburg
Eberhard Karls University of Tübingen
FITT gGmbH, Saarbrücken
BioRegio STERN Management GmbH, Stuttgart
Grasshopper Films GbR, Tübingen

France
Centre Hospitalier Regional et Universitaire de Lille

The Netherlands
Stichting VU, Amsterdam
Motek Medical B.V., Amsterdam
Academisch Ziekenhuis Groningen (University Medical Center Groningen)

Portugal
University of Porto

Switzerland
Gait Up SA, Lausanne

United Kingdom
University of Newcastle upon Tyne
Patients Know Best Ltd, London

The project is financed by the European Union's research and innovation programme in terms of the Marie Sk?odowska-Curie grant agreement (under the funding code 721577).

Media Contact

Dr Walter Maetzler
[email protected]
49-043-150-0239

http://www.uni-kiel.de

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Immune Aging Identified in Earliest Stages of Rheumatoid Arthritis, Offering Promise for Early Intervention

September 8, 2025

Rutgers Study Suggests Nicotine Pouches Could Lead to Reduced Tobacco Harm

September 8, 2025

Duke-NUS Study Uncovers How Dengue Virus Alters Immune System, Impacting Vaccine Efficacy

September 8, 2025

Impact of GLP-1 Receptor Agonists on Cardiovascular and Kidney Outcomes Across BMI Categories in Type 2 Diabetes

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Immune Aging Identified in Earliest Stages of Rheumatoid Arthritis, Offering Promise for Early Intervention

Doping CuO with Sr Enhances Supercapacitor Performance

Rutgers Study Suggests Nicotine Pouches Could Lead to Reduced Tobacco Harm

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.